CTLA-4 has immunoregulatory roles in activated T cells and T-reg cells, and splice site variants that can alter CTLA-4 alternative splicing outcomes can result in T cell hyperactivation, immunodeficiency, and a variable degree of immune dysregulation [31]. Here, CTLA4 is linked to immune system disorder.